SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the June 2025 quarter moved up 33.74% to Rs. 3210.12 millions as compared to Rs. 2400.26 millions during the corresponding quarter last year.The Total Profit for the quarter ended June 2025 of Rs. 248.15 millions grew from Rs.-239.66 millionsOperating profit surged to 851.30 millions from the corresponding previous quarter of 142.59 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3210.12 2400.26 33.74 3210.12 2400.26 33.74 12995.89 1719.19 655.93
Other Income 52.55 39.99 31.41 52.55 39.99 31.41 176.82 42.25 318.51
PBIDT 851.30 142.59 497.03 851.30 142.59 497.03 3869.57 -832.91 -564.58
Interest 270.31 412.26 -34.43 270.31 412.26 -34.43 1616.50 894.16 80.78
PBDT 580.99 -319.18 -282.03 580.99 -319.18 -282.03 1130.57 -2886.41 -139.17
Depreciation 332.84 335.03 -0.65 332.84 335.03 -0.65 1345.12 762.93 76.31
PBT 248.15 -654.21 -137.93 248.15 -654.21 -137.93 -214.55 -3649.34 -94.12
TAX 0.00 -414.55 0.00 0.00 -414.55 0.00 -414.55 0.00 0.00
Deferred Tax 0.00 -414.55 0.00 0.00 -414.55 0.00 -414.55 0.00 0.00
PAT 248.15 -239.66 -203.54 248.15 -239.66 -203.54 200.00 -3649.34 -105.48
Equity 114.46 108.16 5.82 114.46 108.16 5.82 114.43 40.10 185.36
PBIDTM(%) 26.52 5.94 346.41 26.52 5.94 346.41 29.78 -48.45 -161.46

Onesource Specialty Share Price

1819.10 -16.85 (-0.92%)
11-May-2026 09:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.00
Dr. Reddys Lab 1281.55
Cipla 1339.50
Zydus Lifesciences 932.80
Lupin 2282.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×